Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.45 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.42 |
| ▸ | NPY1R | P25929 | 1/20 | 0.42 |
| ▸ | NPY2R | P49146 | 1/20 | 0.42 |
| ▸ | NPY4R | P50391 | 1/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.42 |
| ▸ | NMT1 | P30419 | 1/20 | 0.42 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29475360 | 0.99 | CPB2 (0.47) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL29630356 | 0.93 | FOLH1 (0.50) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL8759327 | 0.91 | FOLH1 (0.53) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL8759318 | 0.91 | FOLH1 (0.53) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL24130548 | 0.91 | FOLH1 (0.53) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL30297530 | 0.90 | OPRK1 (0.40) | CPB2ERAP2ERAP1LNPEPOPRK1 | |
| SCHEMBL31010706 | 0.90 | OPRK1 (0.40) | CPB2ERAP2ERAP1LNPEPOPRK1 | |
| SCHEMBL1370322 | 0.90 | FOLH1 (0.51) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL1370314 | 0.90 | FOLH1 (0.51) | CPB2ERAP2ERAP1LNPEPFOLH1 | |
| SCHEMBL1711325 | 0.90 | CPB2 (0.47) | CPB2ERAP2ERAP1LNPEPFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |